ABSTRACT. Chondrocytes, which are embedded within the growthplate or the intervertebral disc, are sensitive to environmental stresses, such as inflammation and hypoxia. However, little is known about the molecular signaling pathways underlying hypoxia-induced mitochondrial dysfunction and apoptosis in chondrocytes. We first examined the apoptosis, caspase-3 activity, and apoptosis-associated markers in human chondrocyte cell line C28/I2 under normoxia or hypoxia. We then investigated mitochondrial dysfunction and the activation of cyclic adenosine monophosphate response elementbinding protein (CREB) signaling in the same human chondrocyte cell line. Our results indicated that hypoxia induced apoptosis and reduced CREB phosphorylation in chondrocytes. Upregulated mitochondrial superoxide and reactive oxygen species levels, and reduced mitochondrial membrane potential and complex IV activity were observed in hypoxia-treated C28/I2 cells. In conclusion, the present study confirmed reduced CREB phosphorylation, apoptosis induction, and mitochondrial dysfunction in the hypoxia-treated chondrocyte cells. This implies the key role played by CREB signaling in hypoxiainduced mitochondrial dysfunction and apoptosis in chondrocytes.
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INTRODUCTION
Chondrocytes, which are embedded within the growth-plate or the intervertebral disc, survive in an almost avascular and hypoxic milieu, and are sensitive to environmental and multiple cellular stresses, such as inflammation, endoplasmic reticulum(ER) stress and hypoxia (Horton et al., 2006; Chang et al., 2014) . Hypertrophic chondrocytes undergo programmed cell death (apoptosis) during cervical spondylosis or joint disorders involving osteoarthritis (OA) characterized by progressive breakdown of articular cartilage (Triantafillou et al., 2012; Sun et al., 2013) . Reactive oxygen species (ROS) generated by hypoxia/ischemia trigger apoptosis (Misra et al., 2009) .
Mitochondria are the key targets of ROS, which are thought to regulate mitochondrial dysfunction and the promotion of apoptosis. Elevated ROS production causes mitochondrial damage, such as collapse of the mitochondrial membrane potential, and complex IV inactivation, which opens up the mitochondrial permeability transition pores, leading to the release of pro apoptotic proteins into the cytoplasm (Balaban et al., 2005; Choi, 2012) . This causes the release of cytochrome c. Cytochrome c initiates the mitochondria-dependent caspase-3 pathway, which plays a pivotal role in apoptosis (Kroemer et al., 1997; Reed, 1997) . ROS also cause structural and functional damage to mitochondria (Chomyn and Attardi, 2003) . However, little is known about the molecular signaling pathways underlying the mitochondriadependent caspase pathway.
Cyclic adenosine monophosphate (cAMP) response element-binding protein (CREB) is necessary for cell proliferation and apoptosis (Wang et al., 2013) because it regulates the expression of a repertoire of genes associated with cell survival. Those genes include B-cell lymphoma 2 (BCL2), B-cell lymphoma-extra large (BCLXL), and CFOS (Ferron et al., 2011; Han et al., 2013) , and are particularly relevant during hypoxia (Meng et al., 2012) . The inhibition of CREB-Ser133 phosphorylation results in the suppression of anti-apoptotic genes (Aggarwal et al., 2008; Naqvi et al., 2014) . Therefore, CREB signaling might be implicated in hypoxia-induced apoptosis in chondrocytes.
In this study, we first examined hypoxia-induced apoptosis in human chondrocyte cell line C28/I2. We then investigated the activation of CREB and mitochondrial dysfunction in hypoxia-promoted apoptosis in the same cell line. Our results implied the involvement of CREB signaling and mitochondrial dysfunction in the hypoxia-induced apoptosis of chondrocytes.
MATERIAL AND METHODS

Cell culture and treatments
Human chondrocyte C28/I2cells were purchased from the American Type Culture Collection (ATCC) and were cultivated in Dulbecco's modified Eagle's medium (DMEM) (Gibco, Rockville, MD, USA) containing 10% fetal bovine serum (FBS) (Invitrogen, Carlsbad, CA, USA), 100 units/mL penicillin, and 100 mg/mL streptomycin (Sigma-Aldrich, St. Louis, MO, USA) under 5% CO 2 at 37°C. The cells were sub-cultured after reaching approximately 90% confluence. For hypoxia treatment, the cells were placed in a hypoxia incubator with 5% CO 2 and 3% oxygen. Oxygen concentration was monitored continuously (Forma 3130, Thermo Scientific, Rockford, IL, USA).
MTT assay for cellular viability
The cellular viability of the C28/I2 cells was assessed using a3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay kit (Invitrogen, Carlsbad, CA, USA). In brief, C28/I2 cells, post treatment, were mixed with the MTT reagent and incubated at 37°C for 4 h, then treated with dimethyl sulfoxide (DMSO) to dissolve the formazan crystals. Optical densities (ODs) were measured at 450 nm using aspectrophotometer (Bio-Rad, Hercules, CA, USA). Cellular viabilities are presented as average OD 450 values.
Apoptosis assay and caspase-3 assay
Apoptosis induction inC28/I2 cells was investigated using an annex in V/fluorescein isothiocyanate (FITC) apoptosis detection kit (Abcam, Cambridge, UK). In brief, 1x 10 6 post treatmentC28/I2cells were stained with an nexin V-FITC and propidium iodide, and examined using a FACS can flow cytometer (BD Biosciences, San Jose, CA, USA). Apoptosis was evaluated by the percentage of an nexin V-positive cells to total cells.Caspase-3 activity in the C28/I2 cells was determined using a Caspase Senso Lyte kit (for caspase-3) (Ana Spec, Fremont, CA, USA). The cells were collected and washed three times with ice-cold phosphate-buffered saline (PBS), then resuspended in 100 mL (final volume) of a caspase buffer solution supplemented with the fluorogenic peptide substrate Ac-DEVD-AMC for incubation for 30min at 37°C.The caspase-3 activity was determined by assessment of AspGlu-Val-Asp (DEVD)-AMC cleavage in a fluorescence spectrophotometer (Hitachi, Tokyo, Japan) with an excitation wavelength of 390 nm and an emission wavelength of 460 nm. The activity was expressed as percent value of fluorescence intensity of AMC compared with the control.
Western blotting assay
The mitochondrial and cytosolic proteins in C28/I2 cells were isolated using a Mitochondria/Cytosol Fractionation Kit (Abcam, Cambridge, UK), and were supplemented with a protease inhibitor cocktail (Roche). The protein samples were then separated using 12% sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) gels, and were electro-transferred onto nitrocellulose membranes (Millipore). The membranes were incubated with rabbit antibody against cytochrome c (Cytc), caspase-3 (CASP 3), CREB, CREB with Ser133 phosphorylation (all Santa Cruz Biotechnology, Santa Cruz, CA, USA), or b-actin (Sigma-Aldrich, St. Louis, MO, USA). The specific binding signal was then acquired using ECL detection systems by incubation with horseradish peroxidase-conjugated secondary antibodies (Pierce, Rockford, IL, USA).
Measurement of mitochondrial superoxide and ROS
The mitochondrial superoxide was examined using MitoSOX TM Red mitochondrial superoxide indicator (Invitrogen, Carlsbad, CA, USA) (Ex/Em = 510/580 nm), which detects the superoxide in mitochondria with highly selectivity. The C28/I2 cells were incubated with 5 mM MitoSOX TM Red at 37°C for 30 min, then detected after the removal of the reagent and washing three times. The level of intracellular ROS was quantified using ROS-sensitive fluorophore 5-(and-6)-chloromethyl-2,7-dichlorodi-hydrofluorescein diacetate (Invitrogen, Carlsbad, CA, USA) according to the manufacturer instructions. Briefly, confluent C28/I2 cells were incubated with the 5-chloromethyl-2,7-dichlorodihydrofluorescein diacetate probe at 37°C for 30 min and washed three times with PBS. The cells were then rinsed with Hank's balanced salt solution (HBSS) and investigated using a fluorescence spectrophotometer (Hitachi, Tokyo, Japan) with an excitation wavelength of 488 nm and an emission wavelength of 530 nm. The results are reported as a percentage of the control level.
Measurement of mitochondrial membrane potential and complex IV activity
A TMRE-Mitochondrial Membrane Potential Assay Kit (Abcam, Cambridge, UK) was used to determine the mitochondrial membrane potential (MMP) in the C28/I2 cells. C28/ I2 cells (3 x 10 5 ) were incubated with the MMP-sensitive fluorescent TMRE for 30 minutes at 37°C (1000 nM FCCP was added to the positive control cells 10 min prior of TMRE). Cells were then trypsinized, centrifuged, and resuspended in 0.4 mL Dulbecco's phosphatebuffered saline with 0.2% bovine serum albumin and analyzed for TMRE fluorescence using the fluorescence spectrophotometer (Hitachi, Tokyo, Japan) with an excitation wavelength of 575 nm and an emission wavelength of 549 nm. Complex IV activity was measured using a Complex IV Rodent Enzyme Activity Microplate Assay Kit (Abcam, Cambridge, UK) according to the manufacturer instructions. In brief, C28/I2 cells were collected and lysed with the extraction detergent. The protein samples were then serially diluted and incubated at room temperature for 3 hon the plate, in each well of which the enzyme-linked monoclonal antibody against complex IV has immobilized. The binding was then assayed using the fluorescence spectrophotometer (Hitachi, Tokyo, Japan) at an excitation wavelength of 575 nm and an emission wavelength of 549 nm. The results are reported as a percent level of the control.
Statistical analysis
Statistical analyses were performed using SPSS18.0 software (IBM SPSS). All data are reported as means ± standard error of the mean. The Student t-test was performed to determine the differences between two groups. A P value <0.05 was considered statistically significant.
RESULTS
Hypoxia induces apoptosis in chondrocytes
We investigated apoptosis induction by hypoxia in chondrocytes by examining cellular viability using the MTT assay. We investigated apoptosis induction using flow cytometric analysis, and caspase-3 activity using a Caspase SensoLyte kit (for caspase-3) in the chondrocyte C28/I2 cells under hypoxia or normoxia. The MTT assay results ( Figure 1A ) demonstrated that the hypoxia treatment for 24 or 48 h significantly reduced the viability of C28/I2 cells (P < 0.05 or P < 0.01). The apoptosis level was also significantly higher in the hypoxia-treated C28/I2 cells compared with the C28/I2 cells under normoxia ( Figure 1B , P < 0.01 or P < 0.001). The activity of active caspase-3, revealed by the AMC fluorescence intensity in the hypoxia-treated C28/I2 cells, was also significantly higher in the hypoxia group ( Figure 1C) at 12, 24, or 48 h post treatment (H.P.T.) (P < 0.01 or P < 0.001). . Cellular viability and apoptosis in the hypoxia-treated chondrocyte C28/I2 cells. C28/I2 cells were inoculated under hypoxia or normoxia for 12, 24, or 48 h, and were analyzed for cellular viability using a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay for apoptosis using the an nexin V/ FITC apoptosis detection kit, and for caspase-3 activity with an AMC Caspase-3 Assay Kit. MTT assay results (A), percentage of apoptotic cells (B), and percentage of caspase-3 activity (C) of the C28/I2 cells under hypoxia or normoxia are presented, respectively. Each result was averaged for triple independent experiments. Statistical significance is shown as *P < 0.05, **P < 0.01, or ***P < 0.001; ns = no significance.
Hypoxia promotes apoptosis-associated markers and CREB phosphorylation in chondrocytes
To confirm the hypoxia-induced apoptosis in C28/I2 cells, we then analyzed the levels of cytochrome c (Cyt c) released from mitochondria, and activated caspase-3 (cleaved caspase-3, Clv-CASP 3), using western blotting to assay the hypoxia-or normoxia-treated C28/I2 cells. As indicated in Figure 2A , significantly higher levels of Cyt c were released in the hypoxia-treated C28/I2 cells at 12, 24, or 48 h post treatment (P < 0.05, P < 0.01, or P < 0.001). There was a time-dependent upregulation of Cyt c release, with a significant difference between the C28/I2 cells after treatment for 24 and 48 h (P < 0.01, Column 3 vs Column 4, Figure 2B ). Clv-CASP 3 was also markedly promoted by hypoxia treatment after 12, 24, or 48 h (P < 0.01, P < 0.001, or P < 0.0001, Figure 2C ), also with a time-dependence (P < 0.05, Column 3 vs Column 4, Figure 2C ). Each result was averaged for triple independent experiments. Statistical significance is shown as *P < 0.05, **P < 0.01, or ***P < 0.001; ns: no significance.
It is well known that CREB facilitates pro-survival signaling (Dworkin et al., 2009) , and our study investigated the activation of CREB signaling in hypoxia-treated C28/I2 cells. The western blotting assay indicated that phosphorylated CREB was more markedly downregulated in hypoxia-treated C28/I2 cells than in normoxia-treated C28/I2 cells, whereas CREB without phosphorylation was not markedly regulated by hypoxia in C28/I2 cells (P < 0.01 or P < 0.0001, Figure 2A and 2D) , time-dependently (P < 0.01, Column 2 vs Column 3, Figure 2D ). We confirmed apoptosis induction by hypoxia in chondrocyte C28/I2 cells with the downregulation of CREB phosphorylation.
Hypoxia induces mitochondrial dysfunction in chondrocyte C28/I2 cells
We then investigated whether hypoxia induced chondrocyte mitochondrial dysfunction. First, we examined superoxide generation using MitoSOX, a live-cell-permeable and mitochondrial localizing superoxide indicator, in C28/I2 cells under hypoxia or normoxia. As shown in Figure 3A , there was a significantly high level of superoxide in the hypoxia-treated cells at both 24 and 48 h post treatment (P < 0.01 or P < 0.001). Second, we measured ROS production in the hypoxia-treated C28/I2 cells. Figure 3B demonstrates that hypoxia enhanced ROS production from 12 to 48 h post treatment (P < 0.05, P < 0.01, or P < 0.001). However, MMP, a well-confirmed indicator of mitochondrial function, was significantly reduced in the hypoxia-treated C28/I2 cells at 24 or 48 h post treatment (P < 0.05 for 24 H.P.T. or P < 0.01 for 48 H.P.T.) ( Figure 3C ). The activity of mitochondrial respiratory chain complex IV was markedly downregulated in the hypoxia-treated C28/I2 cells ( Figure 3D ), at 12, 24, or 48 h post treatment (P < 0.05, P < 0.01, or P < 0.001). Therefore, hypoxia promotes mitochondrial dysfunction in chondrocyte C28/I2 cells. Mitochondrial dysfunction in the hypoxia-treated C28/I2 cells. C28/I2 cells were inoculated under hypoxia or normoxia for 12, 24, or 48 h, and the percentage of mitochondrial superoxide levels (A), reactive oxygen species (ROS) levels (B), mitochondrial membrane potential (MMP) (C), and complex IV activity (D) were assayed. All results were averaged for three independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001; ns: no significance.
DISCUSSION
Oxygen affects the activity of many types of cell and is involved in many processes that are important for degenerative bone disease (White and Gibson, 2010a; Dalle Carbonare et al., 2015; Vanharanta, 2015) . In this study, we found that hypoxia promoted apoptosis in chondrocyteC28/I2 cells by upregulating caspase-3 activity and inducing mitochondrial dysfunction. Apoptosis can be initiated through membrane receptor-associated and mitochondrial-initiated pathways that converge and mediate downstream apoptosis effects (Hen Gartner, 2000) . Mitochondrial dependence was confirmed in the hypoxiainduced apoptosis ofC28/I2 cells. Mitochondrial dysfunction, such as the overproduction of mitochondrial superoxide and ROS, is one of the most important mechanisms in the response to hypoxia in chondrocytes (Milner et al., 2007; White and Gibson, 2010a; Lane et al., 2015) . However, hypoxia inhibits complexes I, III, and IV (White and Gibson, 2010b) , and MMP (Clérigues et al., 2013) in chondrocytes. Our study confirmed the marked promotion of mitochondrial superoxide and ROS, and the inhibition of MMP and complex IV in hypoxia-treated C28/I2 cells.
Oxidative stress has been implicated in the pathogenesis of osteoporosis. It is conceivable that mitochondrial-mediated ROS generation under oxidative stress leads to the damage of ROS-producing cells and peripheral chondrocytes. As major sources of ROS production, mitochondria are also major targets for ROS attack. The present study demonstrated that oxidative stress mimicked by hydrogen peroxide significantly exerted mitochondrial dysfunction in C28/I2 chondrocyte cells. The anti-oxidative stress effects exerted by allicin have been identified in ischemic/reperfused rats by inhibiting the activation of JNK-1 and C-JUN and further inhibiting apoptosis (Sato et al., 2001) . However, the present study indicated that allicin inhibits ROS generation and ameliorates ROS-induced mitochondrial dysfunction. In addition, allicin treatment ameliorated the repression of PI3K/AKT and CREB/ERK signaling by hydrogen peroxide, and might also be associated with the anti-oxidative stress effect of allicin. Previously, PI3K and CREB have been implicated in chondrocyte-like cell proliferation and differentiation (Carpio et al., 2001; Matsuo et al., 2006) . In the present study, allicin treatment of C28/I2 cells increased PI3K activity, and the phosphorylation of AKT, CREB, and ERK. PI3K is a lipid kinase and generates phosphatidylinositol-3,4,5-trisphosphate, which directly or indirectly affects CREB phosphorylation (Vivanco and Sawyers, 2002) . CREB is a ubiquitous transcription factor in the higher eukaryotes that, once phosphorylated, promotes the synthesis of mitochondrially encoded subunits of oxidative phosphorylation complexes (De Rasmo et al., 2009) . However, since the PI3K/AKT and CREB/ERK signaling pathways are suppressed by hydrogen peroxide, the attenuation of repressed PI3K and CREB by allicin might be caused by reduced hydrogen peroxide toxicity. Moreover, the attenuation of PI3K and CREB repression might ameliorate mitochondrial function by regulating the expression of B-cell lymphoma-2 (Bcl-2) and Bcl-extra large (Bcl-xL) (Boucher et al., 2000) , which are located in the outer membrane of the mitochondria and regulate mitochondrial function (Chan and Yu, 2004) .
In conclusion, the present study confirmed reduced CREB phosphorylation, and apoptosis induction and mitochondrial dysfunction in hypoxia-treated chondrocyte cells. This implies the key role of CREB signaling in hypoxia-induced mitochondrial dysfunction and apoptosis in chondrocytes.
